Market Cap

Calliditas Therapeutics AB (publ) Market Capitalization:

$1.05 Billion

USD as of July 1, 2024

business Calliditas Therapeutics AB (publ) Company Profile

Calliditas Therapeutics AB (publ) Main Stock Listing

NASDAQ: CALT

Market Capitalization History of Calliditas Therapeutics AB (publ)

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Calliditas Therapeutics AB (publ) market cap

Date Market Cap YoY Change
Jan. 1, 2024 $637.2 M 17.56%
Jan. 1, 2023 $542.0 M -6.13%
Jan. 1, 2022 $577.4 M -21.47%
Jan. 1, 2021 $735.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Calliditas Therapeutics AB (publ) Categories

Sweden languages Healthcare languages Drug Manufacturers—Specialty & Generic
Sweden Healthcare Sweden Drug Manufacturers—Specialty & Generic

Stocks & Indices

Calliditas Therapeutics AB (publ) has the following listings and related stock indices.


Stock: NASDAQ: CALT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.